Revivocell & NANOSTACKS™
Revivocell is the company. NANOSTACKS™ is Revivocell's flagship platform.
NANOSTACKS™ is built on a modular, stackable architecture that enables researchers to construct complex multi-layer tissue models that better recreate human physiology in vitro—while remaining compatible with standard laboratory equipment and workflows.
Our Mission
We build human-relevant in vitro systems that improve confidence in preclinical decisions and accelerate drug development.
Improving Drug Development
We focus on creating human-relevant in vitro models to provide pharmaceutical companies with preclinical data that better reflects human biology. This approach aims to support better-informed development decisions.
A Greener World
Our human-relevant in vitro models reduce reliance on animal testing in preclinical research by providing data that is more directly translatable to human biology.
Reducing Reliance on Animal Models
We reduce the need for animal testing in preclinical research through scientifically rigorous, human-relevant in vitro systems.
What Makes Us Different
Transparency
We strive to communicate with you in the clearest manner
From planning to execution, we will always keep the communication lines open, to keep you updated on our progress at every step of the process.
Reliability
We will deliver in a timely manner on mutually agreed deadlines
We will work with you on setting up realistic project timelines to make sure the data is delivered on time.
Flexibility
We will work with you extensively to find the best solution to your needs
Our list of endpoints is open to any option you might suggest, and our models can be customised to better suit your needs.
Human-Relevant Design
Our platforms are designed around human biology rather than animal proxies, improving translational relevance and confidence in preclinical decision-making.
Our Locations
United Kingdom
Headquarters & R&D
Sci-Tech Daresbury is our main location—an innovation hub with over 150 companies. Located between Manchester and Liverpool with strong access to talent and research excellence, Daresbury provides an ideal environment for advancing our microphysiological systems research.
United States
Translational & Industry Engagement
BioLabs® @ NYU Langone, New York
Revivocell Inc.
BioLabs® @ NYU Langone
45-18 Court Square West, Floor 6
Long Island City, NY 11101
United States
Our U.S. presence strengthens collaboration with biotech and pharmaceutical partners, supporting translational alignment and accelerating commercial engagement with leading research institutions.
Our Team
Dr. Valon Llabjani
Founder & CEO
Valon, a PhD holder with 15+ years in biomedical science, excels in managing academic and commercial projects, resulting in patents and funding for Revivocell. His expertise in product design, tissue engineering, and toxicology is widely recognized through 20+ peer-reviewed journal publications, solidifying his position as a top researcher.
Dr. Valmira Hoti
Founder and COO
Dr. Valmira Hoti, with a BSc (Hons) in Banking & Finance and a PhD in Statistics from Lancaster University, directs commercialization strategies and operations at Revivocell. Previously aiding tech start-ups in finance and commercialization in the banking and finance sector, her diverse expertise enhances Revivocell's business success.
Prof. Francis L Martin
Advisory Board
Professor Martin, a globally acclaimed toxicology expert, brings invaluable knowledge to our team with his distinguished record and expertise in various toxicology tests. As the former President of the UK Environmental Mutagen Society and an expert member of the DoH Committee on Mutagenicity, his involvement in regulatory guideline development underscores his renowned reputation. His contributions are pivotal in translating our technology to the market.
Dr Raffaello Sbordoni
Research Scientist
Raffaello, with a Biomedical Engineering background, specialized in advanced liver in vitro models before earning his PhD in Tissue Engineering at University College London, focusing on human airways microphysiological systems. His interdisciplinary expertise in engineering and biology enriches his role as a Research and Development scientist at Revivocell, where he designs and develops complex in vitro models of a variety of human organs, with a focus on the central nervous system.
Dr Abdullah Talari
Head of Biology
Abdullah, with a Ph.D. in Material Science and Tissue Engineering from the University of Sheffield, funded by EPSRC, brings extensive interdisciplinary expertise to Revivocell. He led projects in the FAST Healthcare NetworkPlus Project, focusing on diagnosing colorectal neoplasia. At Revivocell, Abdullah designs and implements research plans for Liver models on microphysiological systems platforms, aiming to advance drug discovery and toxicity assessment.
Dr Ahtasham Raza
Advisory Board
Dr Ahtasham Raza enriches Revivocell with interdisciplinary expertise in 3D soft tissue engineering, bioimaging, and drug discovery. Proficient in working with primary and iPSC cells, he develops accurate models for studying normal and diseased conditions like skin modeling and oncology. His skills in toxicology testing bolster the team's capabilities, advancing innovative solutions in life sciences research.
Dr Imran Patel
Advisory Board
Dr Imran Patel, with a PhD in Biological Sciences from Lancaster University and postdoctoral training at prestigious institutions like the University of Cambridge and Imperial College London NHS Trust, specializes in applying vibrational spectroscopy for cancer bio-sensing and bio-imaging. His expertise supports organ model imaging and clinical translation of the Revivocell organ platforms, advancing cancer research technologies and innovative clinical solutions.
Trusted By
Trusted by leading academic institutions, research hospitals, and innovation partners worldwide.
